Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Dissecting dyskerin

Jonathan B Weitzman

Genome Biology 2003, 4:spotlight-20030115-01  doi:10.1186/gb-spotlight-20030115-01

The electronic version of this article is the complete one and can be found online at:


Published:15 January 2003

© 2003 BioMed Central Ltd

Research news

The DKC1 gene encodes dyskerin, a pseudouridine synthase that binds to box H + ACA small nucleolar RNAs and to the RNA component of telomerase. DKC1 mutations cause dyskeratosis congenital, a rare recessive disease characterized by premature aging and cancer susceptibility. In the January 10 Science, Ruggero et al. describe analysis of a hypomorphic Dkc1 mutant mouse that manifests features of the human disease (Science 2003, 299:259-262). The mice have a two- to four-fold reduction in Dkc1 expression. By six months of age, over half the mice developed dyskeratosis syndrome symptoms, such as severe anemia, lymphopenia, dyskeratosis of the skin, and bone marrow failure. The animals were also highly prone to tumors, especially of the lung and mammary gland. After four generations, mutant mice began to show loss of telomeric repeats and of telomerase activity. The Dkc1 hypomorph provides a useful model of the human disease and demonstrates the importance of its role in rRNA modification.

References

  1. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

    PubMed Abstract OpenURL

  2. [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=305000] webcite

    Dyskeratosis congenita, X-linked

  3. [http://www.sciencemag.org] webcite

    Science